Amunix Operating Inc.
USPTO PatentsView assignee record - 16 granted patents across 8 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Amunix ranks #17,436 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 8 technology areas.
- #17,436
- of 49,997 US assignees by volume
- 45th percentile
- by Innovation Score (33.7/100)
- 23.2
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17436 · US Corporation #17,436 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 16 grants
- MID-PACK #17,436/49,997
- PHOTO-FINISH Aleta Biotherapeutics
- CPC-NARROW C07K · 8 areas
- INNOV-THIN 33.7/100
- CLAIMS-DENSE 23.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Aleta Biotherapeutics Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Amunix’s 33.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Amunix
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Amunix Operating · this assignee 34
Amunix Operating · this assignee
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Amunix's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Amunix?
Each dot is one of Amunix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Amunix’s own 23.2 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Amunix's grants concentrate
Amunix Operating Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2019. By volume, Amunix sits between Aleta Biotherapeutics Inc. and Angion Biomedica Corp..
Who files at Amunix's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Aleta Biotherapeu…
Aleta Biotherapeutics Inc.
16 patents
- Amenity Health
Amenity Health, Inc.
16 patents
- American Leather…
American Leather Operations, LLC
16 patents
- Ammeraal Beltech…
Ammeraal Beltech Modular A/S
16 patents
- Anaren
Anaren, Inc.
16 patents
- Andon Health
Andon Health Co., Ltd.
16 patents
- Angiomed & Medizi…
Angiomed GmbH & Co. Medizintechnik KG
16 patents
- Angion Biomedica
Angion Biomedica Corp.
16 patents
- Amunix Operating ◀
Amunix Operating Inc.
16 patents
What this shows Amunix holds 16 patents at rank #17,452, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Amunix
By rank, the assignees closest to #17,452 in granted patent volume.
- Aleta Biotherapeutics Inc. #17,448 · 16 patents
- Amenity Health, Inc. #17,449 · 16 patents
- American Leather Operations, LLC #17,450 · 16 patents
- Ammeraal Beltech Modular A/S #17,451 · 16 patents
- Anaren, Inc. #17,453 · 16 patents
- Andon Health Co., Ltd. #17,454 · 16 patents
- Angiomed GmbH & Co. Medizintechnik KG #17,455 · 16 patents
- Angion Biomedica Corp. #17,456 · 16 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Amunix's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Amunix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 45th percentile higher than 45% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 25.0% |
| 2016 | 3 | 18.8% |
| 2017 | 3 | 18.8% |
| 2018 | 5 | 31.3% |
| 2019 | 1 | 6.3% |
Which technologies does Amunix Operating Inc. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Amunix Operating Inc.'s patent record in context - here's where to go next.
- Amunix Operating Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #17,436 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Amunix Operating Inc. against Aleta Biotherapeutics Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.